MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2023-24)
- Udyam number
- UDYAM-RJ-17-0022220
_444812.webp)
Vivek Pharmachem (India) Limited - environment in Jaipur, Rajasthan, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹184.19 Cr
▼ 8% YoY
Net profit · FY 2025
₹12.6 Cr
Net margin 6.8%
EBITDA · FY 2025
₹24.25 Cr
EBITDA margin 13.2%
Authorised capital
₹20 Cr
Registered with MCA
Paid-up capital
₹14.25 Cr
Issued & subscribed
Open charges
₹87.65 Cr
Satisfied ₹139.77 Cr
Company age
36 yrs
Est. 1990
Employees · EPFO
51
Provident fund records
About Vivek Pharmachem (India) Limited
Data last updated:
Vivek Pharmachem (India) Limited is a public limited company based in Jaipur, Rajasthan, India. It operates in the wind energy solutions segment of the environmental services sector. It was incorporated on 29 January 1990 and has been in existence for over 36 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24232RJ1990PLC005283. Its GSTIN is 08AAACV6399L1ZK (Rajasthan). The company holds 6 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹20 Cr and a paid-up capital of ₹14.25 Cr. It was formerly known as Vivek Pharmaceuticals Private Limited. It is led by directors including Kuldeep Gupta (Managing Director) and Navdeep Gupta (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 1 Sethi Colony, Jaipur, Rajasthan, India – 302004.
As per the financials filed for FY 2025, the company reported a revenue of ₹184.19 Cr, a decline of 8% compared to the previous year. For the same year it recorded a net profit of ₹12.6 Cr (net margin 6.8%) and EBITDA of ₹24.25 Cr (EBITDA margin 13.2%).
The company has about 51 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
As per MCA filings, the company has open charges of ₹87.65 Cr and satisfied charges of ₹139.77 Cr on record. Court records list 125 cases involving the company, including 92 filed by the company and 33 filed against it; 25 cases are pending. The company has 5 deals on record (4 secondary share transfers, 1 funding round), with disclosed funding of ₹3.52 Cr; the latest was in February 2024. Its 3 peer companies in the Cleantech industry (Formulations, Solar Power, Wind Power), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 1 smaller; the largest is Aet Laboratories Private Limited with revenue of ₹246.84 Cr. The company has 9 MSME Form 1 returns on record between 2019 and 2023, listing 149 overdue payments to 32 micro and small suppliers.
Vivek Pharmachem (India) Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-RJ-17-0022220). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vivekpharma.com.
Company details
CIN U24232RJ1990PLC005283
Registration Number 005283
Incorporation Date 29 January 1990
ROC Jaipur
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-RJ-17-0022220
Recognitions & Rankings of Vivek Pharmachem (India)
Contact details
Vivek Pharmachem (India) Limited's registered office is in Jaipur, Rajasthan. Its website is vivekpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressA – 1 Sethi Colony, Jaipur, Rajasthan, India – 302004
- IndustryEnvironment, Wind Energy Solutions, Solar Energy Solutions
To see the full contact details of Vivek Pharmachem (India) Limited, buy the company report.
Comprehensive company report
Vivek Pharmachem (India) Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activities of Vivek Pharmachem (India) are manufacturing and electricity, gas, steam and air condition supply. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and electric power generation, transmission and distribution. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| D | Electricity, gas, steam and air condition supply | D1 | Electric power generation, transmission and distribution |
To see the full business activity and turnover split of Vivek Pharmachem (India) Limited, buy the company report.
Financials of Vivek Pharmachem (India) Limited
FY 2025 filings availableVivek Pharmachem (India) Limited reported revenue of ₹184.19 Cr (down 8% YoY) for FY 2025.
Revenue · FY 2025
₹184.19 Cr ▼ 8%
Net profit · FY 2025
₹12.6 Cr margin 6.8%
EBITDA · FY 2025
₹24.25 Cr margin 13.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 8%
EBITDA CAGR growth
1 year
▼ 11%
Revenue fell 8% in the latest year. EBITDA fell 11% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹184.19 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹24.25 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹12.6 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.2% | ||||
| Net Profit Margin | 6.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Vivek Pharmachem (India) Limited, buy the company report.
Board of directors of Vivek Pharmachem (India) Limited
Vivek Pharmachem (India) has 8 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Navdeep Gupta Also directs: Vivek Pharmaceuticals Private Limited, Vivek Constructions Pvt Ltd., Uppasana Constructions P. Ltd. and 2 more | Whole-Time Director | 29 Jan 1990 | 36 Years 9 Months | Current |
| Ashwin Gupta Also directs: Vivek Pharmaceuticals Private Limited, Vivek Constructions Pvt Ltd., Uppasana Constructions P. Ltd. and 4 more | Director | 24 Jan 2026 | 0 Years 9 Months | Current |
| Varun Gupta Also directs: Pacific Global Limited, Orchid Medicare Private Limited | Director | 24 Jan 2026 | 0 Years 9 Months | Current |
| Rishi Bhandari Also directs: Medi Rasayan Private Limited | Director | 24 Dec 2024 | 1 Years 10 Months | Current |
| Kuldeep Gupta Also directs: Sunrise Shelters Private Limited, Pacific Global Limited | Managing Director | 23 Feb 1995 | 31 Years 8 Months | Current |
| Savitri Gupta | Director | 07 Mar 2005 | 21 Years 8 Months | Current |
Showing 6 of 8 current directors. View all directors
Peer comparison
Vivek Pharmachem (India) Limited is compared with the 3 companies closest to it by revenue in the Cleantech industry (Formulations, Solar Power, Wind Power), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aet Laboratories Private Limited | ₹246.84 Cr (FY 2025) | 15.0% | Sangareddy, Telangana, India | |||
| Icpa Health Products Ltd | ₹246.81 Cr (FY 2025) | 14.0% | Mumbai, Maharashtra, India | |||
| Blue Circle Organics Private Limited | ₹243.24 Cr (FY 2019) | 35.0% | Mumbai, Maharashtra, India | |||
| Vivek Pharmachem (India) Limitedthis company | ₹184.19 Cr (FY 2025) | ₹12.6 Cr | 6.8% | -8.0% | Jaipur, Rajasthan, India |
To see the full peer comparison of Vivek Pharmachem (India) Limited, buy the company report.
Auditor
Vivek Pharmachem (India) Limited is audited by R Sogani & Associates for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R Sogani & Associates | FY 2024 | 018755C |
Shareholding
The shareholding of Vivek Pharmachem (India) Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Vivek Pharmachem (India) Limited, buy the company report.
Charges & borrowings
Open charges
₹87.65 Cr
Satisfied charges
₹139.77 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 Aug 2026 | 101367056 | Hdfc Bank Limited | ₹2.6 Cr | Open | |
| 27 May 2026 | 101304618 | Hdfc Bank Limited | ₹27.35 Lakh | Open | |
| 27 May 2026 | 101304623 | Hdfc Bank Limited | ₹2.6 Cr | Open | |
| 13 Mar 2024 | 100886040 | Hdfc Bank Limited | ₹12 Cr | Open | |
| 05 Feb 2020 | 100321280 | Hdfc Bank Limited | ₹20.18 Cr | Open |
To see the full charge records of Vivek Pharmachem (India) Limited, buy the company report.
Total charge records: 27 View all charges
Deals & funding
Vivek Pharmachem (India) Limited has 5 deals on record (4 secondary share transfers, 1 funding round), with disclosed funding of ₹3.52 Cr; the latest was in February 2024.
Total deals
5
Secondary share transfers
4
Funding round
1
Disclosed funding
₹3.52 Cr
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2024 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: an individual |
| Sep 2019 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2016 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
| Dec 2008 | Secondary share transfer | Undisclosed | Buyer: Kuldeep Gupta Huf, Navdeep Gupta Huf, 2 individuals Seller: 2 individuals |
| Mar 2006 | Funding round | ₹3.52 Cr | Investors: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Vivek Pharmachem (India) Limited has 125 court cases on record: 92 filed by Vivek Pharmachem (India), 33 filed against it. 25 cases are pending and 100 are disposed.
Total cases
125
Filed by the company
92
Filed against the company
33
Pending
25
Disposed
100
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 91 | 8 | 16 |
| District courts | 34 | 25 | 9 |
Cases on record (5 of 125)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Karnataka | Writ petition | Filed by the company against Karnataka State Medical Supplies Corporation Limited (Ksmscl) | Pending |
| High Court, KARNATAKA | Writ petition | Filed by the company against Karnataka State Medical Supplies Corporation Limited (Ksmscl) | Pending |
| High Court | Writ petition | Filed by the company against Kerala Medical Services Corporation Ltd. and 4 others | Pending |
| High Court of Rajasthan | Writ petition | Filed by the company against Rajasthan Medical Services Corporation Ltd. and 2 others | Disposed |
| High Court | Writ petition | Filed by the company against Rajasthan Medical Services Corporation Ltd. and 3 others | Disposed |
To see the full case history of Vivek Pharmachem (India) Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Vivek Pharmachem (India) Limited was last rated by Crisil on 31 Jan 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 31 Jan 2020 |
To see the full credit ratings and regulatory alerts of Vivek Pharmachem (India) Limited, buy the company report.
MSME payment delays
Vivek Pharmachem (India) Limited has 9 MSME Form 1 returns on record between 2019 and 2023, listing 149 overdue payments to 32 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 32)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| an individual supplier | |||
| Anzen Exports Private Limited | |||
| Imex Overseas | |||
| an individual supplier |
To see the full MSME payment records of Vivek Pharmachem (India) Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Vivek Pharmachem (India) has 1 subsidiary company. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
1
Subsidiary companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Vivek Pharmaceuticals Private Limited | U21001RJ2023PTC089149 |
To see the full group structure of Vivek Pharmachem (India) Limited, buy the company report.
GST
Vivek Pharmachem (India) has 6 GST registrations: 1 active and 5 cancelled or inactive.
Total GSTINs
6
Active
1
Cancelled / inactive
5
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAACV6399L1ZK | Rajasthan | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Vivek Pharmachem (India) Limited, buy the company report.
Recent activity
Vivek Pharmachem (India) Limited has 10 board changes on record since 1990: 8 appointments and 2 cessations. The latest: Aruna Gupta was appointed as Director on 24 Jan 2026.
Charges
A charge registered on 31 Jul 2023 via Charge ID 100762608 with Others was fully satisfied on 29 Aug 2026.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 2.60 Cr with Charge ID 101367056 was registered on 05 Aug 2026.
Charges
A charge registered on 10 Mar 2023 via Charge ID 100691583 with Hdfc Bank Limited was fully satisfied on 08 Jun 2026.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.27 Cr with Charge ID 101304618 was registered on 27 May 2026.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 2.60 Cr with Charge ID 101304623 was registered on 27 May 2026.
Appointed
Aruna Gupta was appointed as Director.
Appointed
Ashwin Gupta was appointed as Director.
Appointed
Varun Gupta was appointed as Director.
AGM
Vivek Pharmachem (India) Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Vivek Pharmachem (India) Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jaipur.
Charges
A charge registered on 09 Mar 2021 via Charge ID 100423824 with Others was fully satisfied on 19 Mar 2025.
Charges
A charge registered on 28 Oct 2020 via Charge ID 100381292 with Others was fully satisfied on 19 Mar 2025.
57 earlier events are in the company report.
Frequently asked questions
Vivek Pharmachem (India) is an active public limited company based in Jaipur, Rajasthan, India. The company works in wind energy solutions, within the environment industry. It was incorporated on 29 January 1990 (36+ years old) and is registered under CIN U24232RJ1990PLC005283.
Vivek Pharmachem (India) has 8 current directors:
- Kuldeep Gupta - Managing Director
- Navdeep Gupta - Whole-Time Director
- Ashwin Gupta - Director
- Varun Gupta - Director
- Rishi Bhandari - Director
- Savitri Gupta - Director
- Rahul Bhandari - Director
- Aruna Gupta - Director
The latest financial statements of Vivek Pharmachem (India) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Vivek Pharmachem (India) is 08AAACV6399L1ZK, registered in Rajasthan. The company has 6 GST registrations in all, of which 1 is active and 5 are cancelled or inactive.
The CIN (Corporate Identification Number) of Vivek Pharmachem (India) is U24232RJ1990PLC005283. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vivek Pharmachem (India) has 125 court cases on record: 92 filed by the company and 33 filed against it. 25 are pending. Most are in the high courts.
Vivek Pharmachem (India) was incorporated on 29 January 1990, making it 36+ years old. It is registered with the Registrar of Companies, Jaipur.
Vivek Pharmachem (India) has 5 deals on record (4 secondary share transfers, 1 funding round), with disclosed funding of ₹3.52 Cr; the latest was in February 2024.
The peers of Vivek Pharmachem (India) by revenue are Aet Laboratories Private Limited, Icpa Health Products Ltd, Blue Circle Organics Private Limited, all in the Cleantech industry (Formulations, Solar Power, Wind Power), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Aruna Gupta was appointed as Director on 24 Jan 2026. Ashwin Gupta was appointed as Director on 24 Jan 2026. Varun Gupta was appointed as Director on 24 Jan 2026. Vivek Pharmachem (India) has 10 board changes on record in total.
Yes, Vivek Pharmachem (India) is registered as a medium enterprise under Udyam registration (number: UDYAM-RJ-17-0022220).
Vivek Pharmachem (India) has 9 MSME Form 1 returns on record between 2019 and 2023, listing 149 overdue payments to 32 micro and small suppliers. The latest return was filed on 03 Dec 2023.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages